REGN

Regeneron Pharmaceuticals, Inc. News Headlines

$351.54
*  
2.51
0.71%
Get REGN Alerts
*Delayed - data as of Aug. 27, 2014 10:40 ET  -  Find a broker to begin trading REGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    REGN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

7 Things Regeneron Pharmaceuticals Inc.'s Management Wants You to Know
8/26/2014 9:56:04 PM - Motley Fool

Why I Bought Into Monday's Move In Regeneron
8/26/2014 11:16:00 AM - Seeking Alpha

Nasdaq 100 Movers: INTU, GILD
8/25/2014 11:41:48 AM - BNK Invest

Avalanche Biotechnologies' Quiet Period Expiration Provides Opportunity
8/25/2014 7:47:00 AM - Seeking Alpha

European Stocks Tipped For Higher Open
8/25/2014 2:08:00 AM - RTT News

Regeneron, Sanofi To Present Results From Four Phase 3 Alirocumab Trials At ESC
8/25/2014 1:15:00 AM - RTT News

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update
8/23/2014 10:34:00 AM - Seeking Alpha

Cramer's Mad Money - 12 Stocks That Have Performed Better Than Google (8/21/14)
8/22/2014 6:22:00 AM - Seeking Alpha

Regeneron's Eye Drug Eylea Cleared in the EU for DME - Analyst Blog
8/12/2014 5:20:00 PM - Zacks.com

The Case That Regeneron May Be Significantly Undervalued
8/8/2014 10:42:00 AM - Seeking Alpha

Biotech Stock Roundup: Amgen Plans Job Cuts, Regeneron's Eylea Continues to Impress - Analyst Blog
8/6/2014 12:00:00 PM - Zacks.com

Regeneron Misses on Earnings in Q2, Eylea Drives Sales Beat - Analyst Blog
8/5/2014 3:02:00 PM - Zacks.com

Nasdaq 100 Movers: EXPD, WFM
8/5/2014 12:21:38 PM - BNK Invest

Sector Update: Health Care Stocks Weighed in Pre-Market Trade
8/5/2014 8:25:25 AM - MT Newswires

Sector Update: Health Care
8/5/2014 8:20:15 AM - MT Newswires

Regeneron Pharma Q2 Profit Increases - Quick Facts
8/5/2014 6:42:00 AM - RTT News

Cramer's Mad Money - 4 Charts With Fangs (8/4/14)
8/5/2014 5:52:00 AM - Seeking Alpha

Pre-Market Earnings Report for August 5, 2014 : CVS, EMR, ACT, REGN, ADM, HCP, MMP, ZTS, MSI, FE, MGM, IEP
8/4/2014 4:00:01 PM - NASDAQ.com News

BioMarin Q2 Loss Narrower than Expected, Revenue Guidance Up - Analyst Blog
7/31/2014 5:00:00 PM - Zacks.com

Regeneron's Eylea Gets FDA Nod for Diabetic Macular Edema - Analyst Blog
7/30/2014 7:00:00 PM - Zacks.com

BioMarin Sells Priority Review Voucher To Regeneron
7/30/2014 5:42:00 PM - Dow Jones Business News

S&P 500 Movers: GNW, EW
7/30/2014 11:28:22 AM - BNK Invest

Nasdaq 100 Movers: GRMN, REGN
7/30/2014 11:27:43 AM - BNK Invest

Regeneron Pharmaceuticals Inc. (REGN) Is Surging On Phase 3 Study Results
7/30/2014 9:32:00 AM - RTT News

Sanofi And Regeneron: 9 Phase 3 ODYSSEY Trials Of Alirocumab Met Primary Goal
7/30/2014 8:19:00 AM - RTT News